{"podcast":{"title":"The AI in Business Podcast","slug":"the-ai-in-business-podcast-168928","podcast_index_feed_id":168928,"rss_url":"https://techemergence.libsyn.com/rss","website_url":"http://emerj.com","image_url":"https://static.libsyn.com/p/assets/9/c/2/2/9c226d0d338dd5bed959afa2a1bf1c87/1.png","author":"Daniel Faggella","episode_count":1163,"summary":"The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj research staff and journalists interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise","last_synced_at":"2026-07-04T00:20:08.438260+00:00","page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928"},"episode":{"title":"From Overwhelm to Working AI in Pharma and Life Sciences - with Art Shectman of Elephant Ventures","slug":"from-overwhelm-to-working-ai-in-pharma-and-life-sciences-with-art-shectman-of-elephant-ventures","published_at":"2026-06-08T06:00:00+00:00","page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928/from-overwhelm-to-working-ai-in-pharma-and-life-sciences-with-art-shectman-of-elephant-ventures","show_page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928","url":"https://podcast.emerj.com/from-overwhelm-to-working-ai-in-pharma-and-life-sciences-with-art-shectman-of-elephant-ventures","audio_url":"https://traffic.libsyn.com/secure/techemergence/Ed_Elephant_Ventures_Final_Audio_Art_Shectman_ep2_1.mp3?dest-id=151434","summary":"Regulatory volatility, scientific‑grade context requirements, and entrenched legacy processes are creating a level of operational complexity in pharma that makes even high‑value AI initiatives difficult to move from concept to production. In this episode, Art Shectman, CEO at Elephant Ventures, examines with host Marilie Fouché how leaders can cut through that complexity by isolating a single, clearly defined workflow slice and rebuilding it for near‑term, dependable deployment rather than long‑range architectural perfection. The discussion highlights how removing outdated process assumptions, selecting an atomic workflow with organizational alignment, and aiming for a contained operational win enable pharma teams to build momentum and scale AI responsibly in highly regulated environments. Learn how consultants are winning business with evidence-based AI ROI and building long-term capabilities instead of chasing short-term gains. Download our free PDF report, \"3 Keys to Thriving in the Coming Era of Automation,\" at emerj.com/cok1","meta_description":"Regulatory volatility, scientific‑grade context requirements, and entrenched legacy processes are creating a level of operational complexity in pharma tha…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2041,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-ai-in-business-podcast-168928/episodes/from-overwhelm-to-working-ai-in-pharma-and-life-sciences-with-art-shectman-of-elephant-ventures/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928/from-overwhelm-to-working-ai-in-pharma-and-life-sciences-with-art-shectman-of-elephant-ventures.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}